丹麥雷度 Radiometer
作為危急癥檢測領域的領導者,丹麥雷度專注于為危急癥檢測中的每一環節提供技術先進的解決方案。其全方位的解決方案涵蓋了血氣分析,經皮檢測及包括心臟、血凝、感染及妊娠標志物方面的免疫檢測。
憑借我們快速精準的危急癥診斷結果,醫護人員能夠做出及時有效的判斷,并進一步在重癥監護室(ICUs)、急診(EDs)和手術室(Ors)等危急癥檢測部門改進病患關懷及優化病患流動管理。
雷度成立于1935年,總部位于丹麥的哥本哈根。作為血氣檢測的先驅,雷度于1954年推出了世界上第一臺商用血氣分析儀。
通過全資子公司和授權經銷商,雷度為全球100多個國家提供產品和服務。雷度米特醫療設備(上海)有限公司作為丹麥雷度在中國大陸及港澳臺地區的全資子公司。
雷度隸屬于,集團總部擁有約48,000名員工,分布在全球50個公司(NYSE:DHR)。
Radiometer is the world leader in the development, manufacture and distribution of technologically advanced critical care testing systems for blood gas, electrolytes and metabolites.
The company offers complete solutions to the complex process of blood gas analysis through the use of innovative instrumentation, sampling products and information technology, supported by world-class customer and technical support.
Radiometer’s blood gas testing solutions meet the needs of both the traditional central laboratory and the increasing number of point of care sites in today’s hospital environment.
Radiometer is owned by the Danaher Corporation.
Radiometer Pacific P/L
Radiometer Pacific is the Australasian market leader in the field of high technology medical instrumentation. Radiometer Pacific employs over 30 staff throughout Australia and New Zealand in sales and support for the products that we sell.
For more information about how Radiometer Pacific is organised, go to Group Structure.
For the history of Radiometer Pacific, go to History.
Our way: Red System
Radiometer's high-quality and cost-effective solutions for diagnosing critically ill patients are customized with the Red System, Radiometer's approach for analyzing individual hospitals' needs and tailoring optimized solutions for them. Read more about the Red System.